NEOFLUIDICS, LLC

Medtech · Private

Millifluidic device for automated handling, alignment, and high-throughput screening of zebrafish embryos in drug discovery

neofluidics.com →
Grants
$400K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
20
3 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A nano-liter 3D cell culture well plate for high-throughput screening$225,000
Federal grantDepartment of Health and Human Services · Phase I · A millifluidic platform for automated dechorionation, capture and screening of Zebrafish$175,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1274HYPERMELT, LLC——
1275Cellia Science, Inc.—$300K
1276PIEZO ENERGY TECHNOLOGIES, LLC——
1277NEOFLUIDICS, LLC——
1278Balanced Pharma Inc—$3.2M
1279ASSIST EQUIPMENT DEVELOPMENT, INC.——
1280INOVASC, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 20

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.